These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 22959924)

  • 21. Association of NT-proBNP with plasma renin activity and plasma aldosterone concentration in women with singleton pregnancy.
    Yamada T; Koyama T; Furuta I; Takeda M; Nishida R; Yamada T; Morikawa M; Minakami H
    Pregnancy Hypertens; 2014 Jan; 4(1):23-8. PubMed ID: 26104250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between N-terminal pro-B-type natriuretic peptide plasma levels and renal function evaluated with different formulae in older adult subjects admitted because of dyspnea.
    Fabbian F; De Giorgi A; Portaluppi F; Zuliani G
    Gerontology; 2012; 58(1):50-5. PubMed ID: 21540563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-terminal pro brain natriuretic peptide reflects long-term complications in type 1 diabetes.
    Grauslund J; Nybo M; Green A; Sjølie AK
    Scand J Clin Lab Invest; 2010 Oct; 70(6):392-8. PubMed ID: 20575653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumour necrosis factor {alpha} blockade reduces circulating N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis: results from a prospective cohort study.
    Peters MJ; Welsh P; McInnes IB; Wolbink G; Dijkmans BA; Sattar N; Nurmohamed MT
    Ann Rheum Dis; 2010 Jul; 69(7):1281-5. PubMed ID: 19934107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-terminal pro-brain natriuretic protein levels in takotsubo cardiomyopathy.
    Nguyen TH; Neil CJ; Sverdlov AL; Mahadavan G; Chirkov YY; Kucia AM; Stansborough J; Beltrame JF; Selvanayagam JB; Zeitz CJ; Struthers AD; Frenneaux MP; Horowitz JD
    Am J Cardiol; 2011 Nov; 108(9):1316-21. PubMed ID: 21871590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-terminal pro-brain natriuretic peptide (NT-proBNP) in Type 2 diabetes with left ventricular dysfunction.
    Kim JY; Lee EY; Jee JH; Lee BW; Chung JH; Jeun ES; Min YK; Lee MS; Kim KW; Lee MK
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S238-42. PubMed ID: 17490778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perinatal changes of circulating N-terminal pro B-type natriuretic peptide (NT-proBNP) in normal and intrauterine-growth-restricted pregnancies.
    Iacovidou N; Briana DD; Boutsikou M; Gourgiotis D; Baka S; Vraila VM; Hassiakos D; Malamitsi-Puchner A
    Hypertens Pregnancy; 2007; 26(4):463-71. PubMed ID: 18066964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease.
    Hess G; Runkel S; Zdunek D; Hitzler WE
    Clin Lab; 2005; 51(3-4):167-72. PubMed ID: 15819172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early second-trimester plasma levels of NT-proBNP in women who subsequently develop early-onset preeclampsia.
    Junus K; Wikström AK; Larsson A; Olovsson M
    J Matern Fetal Neonatal Med; 2017 Sep; 30(18):2163-2165. PubMed ID: 27677676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-terminal pro-brain natriuretic peptide in cases with metabolic syndrome and its relationship with components of metabolic syndrome and left ventricular mass index.
    Sezen Y; Baş M; Demirbag R; Yildiz A; Celik H; Aksoy S
    Clin Biochem; 2009 Oct; 42(15):1500-3. PubMed ID: 19615987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated plasma N-terminal pro-brain natriuretic peptide levels in acute ischemic stroke.
    Iltumur K; Yavavli A; Apak I; Ariturk Z; Toprak N
    Am Heart J; 2006 May; 151(5):1115-22. PubMed ID: 16644347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.
    Krauser DG; Lloyd-Jones DM; Chae CU; Cameron R; Anwaruddin S; Baggish AL; Chen A; Tung R; Januzzi JL
    Am Heart J; 2005 Apr; 149(4):744-50. PubMed ID: 15990762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study.
    Das SR; Drazner MH; Dries DL; Vega GL; Stanek HG; Abdullah SM; Canham RM; Chung AK; Leonard D; Wians FH; de Lemos JA
    Circulation; 2005 Oct; 112(14):2163-8. PubMed ID: 16203929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive value of serum NT-proBNP levels in type 2 diabetic people with diabetic nephropathy.
    Danis R; Ozmen S; Arikan S; Gokalp D; Alyan O
    Diabetes Res Clin Pract; 2012 Mar; 95(3):312-6. PubMed ID: 22018780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of second-trimester maternal serum free-beta-human chorionic gonadotropin and alpha-fetoprotein between normal singleton and twin pregnancies: a population-based study.
    Zheng MM; Hu YL; Zhang CY; Ru T; Liu QL; Xu BY; Chen QG; Xu ZF; Zhang Y; Zhong XL
    Chin Med J (Engl); 2010 Mar; 123(5):555-8. PubMed ID: 20367980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Influencing factors for the plasma concentration of N-terminal brain natriuretic peptide precursor in patients with heart failure due to various heart diseases].
    Wei BQ; Zhang J; Yang YJ; Zhang YH; Huang XH; Yu LT; Zhou Q; Tan HQ; Yang YM; Wang GG; Zhu J
    Zhonghua Yi Xue Za Zhi; 2011 Oct; 91(38):2683-7. PubMed ID: 22321977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women.
    Ardawi MS; Nasrat HA; Rouzi AA; Qari MH; Al-Qahtani MH; Abuzenadah AM
    Prenat Diagn; 2007 Apr; 27(4):303-11. PubMed ID: 17269128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.
    David S; Kümpers P; Seidler V; Biertz F; Haller H; Fliser D
    Nephrol Dial Transplant; 2008 Apr; 23(4):1370-7. PubMed ID: 18089624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea.
    Bayes-Genis A; Lloyd-Jones DM; van Kimmenade RR; Lainchbury JG; Richards AM; Ordoñez-Llanos J; Santaló M; Pinto YM; Januzzi JL
    Arch Intern Med; 2007 Feb; 167(4):400-7. PubMed ID: 17325303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum and pleural fluid N-Terminal-Pro-B-Type natriuretic peptide concentrations in the differential diagnosis of pleural effusions.
    Yorgancıoğlu A; Ozgen Alpaydın A; Yaman N; Taneli F; Bayturan O; Sakar Coşkun A; Celik P
    Tuberk Toraks; 2011; 59(1):1-7. PubMed ID: 21554224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.